The Company’s CovaWound™, ColActive®, and MediClear™ PreOp brands have strong evidence to support their efficacy in killing the bacteria most commonly associated with infections in surgical procedures and chronic diabetic foot wounds. When used together, ColActive and CovaWound help to promote rapid closure of chronic wounds.
“This will be Covalon’s first time exhibiting at the Limb Salvage and Woundcare Symposium”, said
The increasing incidence of diabetic foot ulcers and wounds creates challenges for practitioners regarding strategies to treat this complex comorbidity. As a result, practitioners are constantly looking to stay abreast of the most recent advances and techniques to help those patients not responding to other less advanced medical products. Covalon’s CovaWound and ColActive Plus product lines provide clinicians with the advanced technologies needed to help chronic wound patients to heal.
This year's program brings together the most renowned lower limb specialists to discuss the latest education and outcomes needed to heal wounds and prevent amputations.